Do serum cTnT and LV contractility identify subclinical cardiac damage in pediatric patients with chronic renal failure?
Serum cTnT and LV contractility can identify subclinical cardiac damage in pediatric chronic renal failure, potentially guiding early interventions to reduce cardiovascular morbidity.
Elevated cTnT levels are not artifactual, but are genuine indicators of cardiomyocyte damage. Cardiac damage, indicated by either elevated cTnT or low LV contractility, is related to uremia, deranged calcium and phosphorus metabolism, and bicarbonate levels. Serum cTnT and LV contractility identify subclinical cardiac damage that could be treated to hopefully reduce cardiovascular morbidity and mortality in this high-risk population.
Lipshultz et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: